U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07616752) titled 'The Impact of Salmon Protein Hydrolysate (SPH / ProGo(R)) Supplementation on Hematologic and Metabolic Health' on May 14.
Brief Summary: Healthy, overweight males and females randomised to receive 8-weeks of salmon protein hydrolysate SPH (12g daily) or whey protein isolate (12g daily) to assess the impact on red blood cell and ferritin levels, blood glucose levels, BMI, percent body fat and lean body mass along with hair, skin and nail health and blood biomarkers of inflammation.
Study Start Date: July 19, 2019
Study Type: INTERVENTIONAL
Condition:
Overweight (BMI > 25)
Weight Loss
Intervention:
OTHER: Nutritional supplementat...